Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-05-08 22:16:22 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Investor Conference Webinar about Recent Developments
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on May 15, 2013 at 16:00 (EET).
Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
topics in relation to AS “Olainfarm” expansion plans and analysis
of company’s recent activities and financial results will be
discussed. After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till May 14 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar A/s OlainFarm is one of the
biggest pharmaceutical companies in Latvia with 40 years of
experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information prepared by:
e-mail:
Salvis.Lapins@OlainFarm.lv |
Pielikumi |
|